Pradip Shah, MD
Geriatric Medicine · West Caldwell, NJNPI 1326059320
Payments from drug & device makers
Across 487 payments — averaging $54.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Avanir Pharmaceuticals, Inc.$9K
- Sunovion Pharmaceuticals Inc.$6K
- Novartis$2K
- Teva Pharmaceuticals USA, Inc.$1K
- Johnson & Johnson$1K
- AbbVie$908
- plus $6K from 31 others
What the payments were for
- Consulting fees$1,7527%
- Speaking & faculty fees$13,43750%
- Travel & lodging$4282%
- Food & beverage$10,58640%
- Education$4712%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Avanir Pharmaceuticals, Inc. | 33 | $8,835 |
| Sunovion Pharmaceuticals Inc. | 55 | $6,101 |
| Novartis | 17 | $2,371 |
| Teva Pharmaceuticals USA, Inc. | 54 | $1,171 |
| Johnson & Johnson | 34 | $1,096 |
| AbbVie(2 entities) | 41 | $908 |
| Pfizer | 33 | $627 |
| Amgen | 15 | $619 |
| Astellas Pharma US Inc | 20 | $614 |
| Otsuka America Pharmaceutical, Inc. | 27 | $475 |
| Sumitomo Pharma America, Inc. | 25 | $439 |
| Merck | 28 | $418 |
| Acadia Pharmaceuticals Inc | 9 | $407 |
| AstraZeneca | 6 | $363 |
| Lilly USA, LLC | 18 | $312 |
| Eisai Inc. | 5 | $269 |
| Novo Nordisk | 10 | $243 |
| CMP Pharma, Inc. | 11 | $152 |
| Amarin Pharma, Inc. | 4 | $131 |
| Biogen | 8 | $126 |
| GSK | 1 | $125 |
| E.r. Squibb & Sons, L.L.C. | 1 | $118 |
| Optinose US, Inc. | 1 | $117 |
| Intuity Medical Inc | 1 | $104 |
| Biotronik Inc. | 1 | $79 |
| Nestle Healthcare Nutrition Inc. | 5 | $72 |
| Aimmune Therapeutics, Inc. | 4 | $69 |
| Scilex Pharmaceuticals Inc. | 5 | $68 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $50 |
| Lundbeck LLC | 3 | $49 |
| Neurelis, Inc. | 3 | $49 |
| Aquestive Therapeutics, Inc. | 1 | $25 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
| Shionogi Inc | 1 | $17 |
| Harmony Biosciences LLC | 1 | $14 |
| Acorda Therapeutics, Inc | 1 | $12 |
| Mylan Specialty L.p. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$26,674 in reported general payments places this provider in the 95th percentile of 165 geriatric medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 566 | $284,230 |
| EntrestoSacubitril/Valsartan | 107 | $65,922 |
| XareltoRivaroxaban | 112 | $59,180 |
| RexultiBrexpiprazole | 36 | $58,864 |
| MyrbetriqMirabegron | 107 | $48,975 |
| TradjentaLinagliptin | 69 | $33,172 |
| JardianceEmpagliflozin | 61 | $30,694 |
| TrulicityDulaglutide | 44 | $27,130 |
| JanuviaSitagliptin Phosphate | 35 | $21,300 |
| AbrysvoRsv Vacc, Pref A And Pref B/Pf | 64 | $20,324 |
| AptiomEslicarbazepine Acetate | 17 | $20,015 |
| ZenpepLipase/Protease/Amylase | 12 | $19,307 |
| MounjaroTirzepatide | 15 | $16,657 |
| Breo ElliptaFluticasone/Vilanterol | 30 | $13,749 |
| FarxigaDapagliflozin Propanediol | 19 | $13,478 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Abrysvo | $627 | $304,555630 claims |
| NovartisEntresto | $2,371 | $65,922107 claims |
| Johnson & JohnsonXarelto | $1,096 | $59,180112 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $475 | $58,86436 claims |
| Astellas Pharma US IncMyrbetriq | $614 | $48,975107 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $312 | $43,78759 claims |
| GSKBreo Ellipta, Trelegy Ellipta, Shingrix | $125 | $35,23689 claims |
| AstraZenecaFarxiga, Brilinta | $363 | $24,58443 claims |
| MerckJanuvia | $418 | $21,30035 claims |
| Sunovion Pharmaceuticals Inc.Aptiom | $6,101 | $20,01517 claims |
| Aimmune Therapeutics, Inc.Zenpep | $69 | $19,30712 claims |
| AbbVieNamzaric | $908 | $11,43211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 165 geriatric medicine providers in New Jersey.
Other geriatric medicine in West Caldwell
- Isao IwataPlainsboro$783K
- Albert RiddleHaworth$524K
- Joshua Shua HaimManchester$192K
- Gamil MakarClifton$82K
- Gregorio GuillenPerth Amboy$8K
- Ketankumar VaidyaEdison$8K
- Cheng-An MaoClifton$8K
- Theresa RedlingLivingston$7K
- Sarita RastogiHackensack$7K
- Leslie FeiginDenville$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.